1,258
Views
4
CrossRef citations to date
0
Altmetric
Research Paper

Co-targeting CK2α and YBX1 suppresses tumor progression by coordinated inhibition of the PI3K/AKT signaling pathway

, , , , , ORCID Icon, , , , , & show all
Pages 3472-3490 | Received 04 Apr 2019, Accepted 24 Sep 2019, Published online: 12 Nov 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (3)

Jiayu Chen, Zhanliang Liu, Huicheng Zhang, Yongqian Yang, Huangxiang Zeng, Rongwei Zhong, Shangdao Lai & Hongxing Liao. (2023) YBX1 Promotes MSC Osteogenic Differentiation by Activating the PI3K/AKT Pathway. Current Stem Cell Research & Therapy 18:4, pages 513-521.
Crossref
Hongmei Wang, Fang Guo, Mengyan Du, Guishen Wang & Chen Cao. (2022) A novel method for drug-target interaction prediction based on graph transformers model. BMC Bioinformatics 23:1.
Crossref
Beate Maria Schmitt, Emmanuel Ampofo, Heike Stumpf, Mathias Montenarh & Claudia Götz. (2020) The stability of CREB3/Luman is regulated by protein kinase CK2 phosphorylation. Biochemical and Biophysical Research Communications 523:3, pages 639-644.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.